Preventing Catheter-Related Bloodstream Infections with Joe Todisco CorMedix TRANSCRIPT
Download PDFJul 25, 2023
Joe Todisco, CEO of CorMedix, is developing a product that has broad spectrum activity against bacteria and fungus to impact the safety of receiving hemodialysis through a central venous catheter. With the recent acceptance by the FDA of the submission for DefenCath, CorMedix is hopeful of obtaining FDA approval...
Jul 25, 2023
Joe Todisco, CEO of CorMedix, is developing a product that has broad spectrum activity against bacteria and fungus to impact the safety of receiving hemodialysis through a central venous catheter. With the recent acceptance by the FDA of the submission for DefenCath, CorMedix is hopeful of obtaining FDA approval...
Inhalation Vaccines Changing Options to Prevent and Control Transmission of Flu and COVID with Dr. Shankar Musunuri Ocugen TRANSCRIPT
Download PDFMay 13, 2023
Dr. Shankar Musunuri is the Co-Founder and CEO of Ocugen, which is a biotechnology company focused on vaccines for public health, gene therapies targeting rare diseases in the retinal space, and cell therapies for regenerative medicine applications in cartilage repair. One key opportunity is to develop an...
May 13, 2023
Dr. Shankar Musunuri is the Co-Founder and CEO of Ocugen, which is a biotechnology company focused on vaccines for public health, gene therapies targeting rare diseases in the retinal space, and cell therapies for regenerative medicine applications in cartilage repair. One key opportunity is to develop an...
Oral Gut Microbiome Treatment for Recurrent C. diff with Eric Shaff Seres Therapeutics TRANSCRIPT
Download PDFMay 1, 2023
Eric Shaff is the President and CEO of Seres Therapeutics, which is focused on the gut microbiome in order to develop bacteria as an oral treatment for bloodstream infections, cancer, and immune system diseases. The first therapy is SER-109 for recurrent C. diff infection an orphan disease with inadequate solutions...